HM Payson & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Sell
59,042
-3,388
-5% -$296K 0.07% 118
2026
Q1
$5.32M Sell
62,430
-1,668
-3% -$149K 0.08% 114
2025
Q4
$5.07M Sell
64,098
-1,200
-2% -$94.1K 0.07% 109
2025
Q3
$5.22M Sell
65,298
-2,459
-4% -$210K 0.08% 102
2025
Q2
$6.16M Sell
67,757
-774
-1% -$70.7K 0.1% 92
2025
Q1
$6.42M Sell
68,531
-1,697
-2% -$152K 0.11% 89
2024
Q4
$6.38M Buy
70,228
+137
+0.2% +$13.1K 0.11% 88
2024
Q3
$7.28M Sell
70,091
-274
-0.4% -$27.9K 0.12% 91
2024
Q2
$6.83M Buy
70,365
+100
+0.1% +$9.22K 0.12% 87
2024
Q1
$6.33M Buy
70,265
+99
+0.1% +$8.39K 0.12% 94
2023
Q4
$5.59M Sell
70,166
-2,145
-3% -$161K 0.12% 98
2023
Q3
$5.14M Sell
72,311
-2,046
-3% -$153K 0.12% 97
2023
Q2
$5.73M Sell
74,357
-2,750
-4% -$213K 0.13% 92
2023
Q1
$5.79M Buy
77,107
+799
+1% +$59.4K 0.14% 89
2022
Q4
$6.01M Sell
76,308
-752
-1% -$56.4K 0.15% 81
2022
Q3
$5.41M Buy
77,060
+1,205
+2% +$94.5K 0.15% 87
2022
Q2
$6.08M Sell
75,855
-198
-0.3% -$15.5K 0.16% 88
2022
Q1
$5.77M Sell
76,053
-2,997
-4% -$237K 0.13% 95
2021
Q4
$6.75M Buy
79,050
+1,253
+2% +$97.8K 0.15% 94
2021
Q3
$5.88M Sell
77,797
-1,469
-2% -$117K 0.14% 96
2021
Q2
$6.45M Sell
79,266
-4,093
-5% -$335K 0.16% 94
2021
Q1
$6.57M Sell
83,359
-3,471
-4% -$272K 0.17% 90
2020
Q4
$7.42M Sell
86,830
-8,771
-9% -$725K 0.21% 85
2020
Q3
$7.38M Buy
95,601
+2,041
+2% +$156K 0.23% 80
2020
Q2
$6.85M Sell
93,560
-1,250
-1% -$88.8K 0.23% 80
2020
Q1
$6.29M Sell
94,810
-14,044
-13% -$990K 0.25% 76
2019
Q4
$7.49M Sell
108,854
-4,147
-4% -$283K 0.24% 82
2019
Q3
$8.31M Sell
113,001
-2,441
-2% -$177K 0.29% 73
2019
Q2
$8.27M Sell
115,442
-3,173
-3% -$225K 0.3% 72
2019
Q1
$8.13M Buy
118,615
+117,415
+9,785% +$7.58M 0.31% 70
2018
Q4
$71K Sell
1,200
-124,729
-99% -$7.8M 0.21% 78
2018
Q3
$8.43M Sell
125,929
-13,890
-10% -$925K 0.38% 59
2018
Q2
$9.06M Sell
139,819
-3,109
-2% -$203K 0.39% 62
2018
Q1
$10.2M Sell
142,928
-5,879
-4% -$423K 0.42% 63
2017
Q4
$11.2M Sell
148,807
-6,085
-4% -$444K 0.45% 58
2017
Q3
$11.3M Sell
154,892
-3,027
-2% -$218K 0.49% 56
2017
Q2
$11.7M Sell
157,919
-3,481
-2% -$258K 0.53% 52
2017
Q1
$11.8M Sell
161,400
-5,057
-3% -$354K 0.54% 56
2016
Q4
$10.9M Sell
166,457
-4,009
-2% -$275K 0.52% 59
2016
Q3
$12.6M Sell
170,466
-13,862
-8% -$1.02M 0.62% 57
2016
Q2
$13.5M Sell
184,328
-1,124
-0.6% -$80K 0.67% 51
2016
Q1
$13.1M Sell
185,452
-1,117
-0.6% -$74.3K 0.68% 48
2015
Q4
$12.4M Buy
186,569
+3,696
+2% +$246K 0.64% 50
2015
Q3
$11.6M Sell
182,873
-289
-0.2% -$18.9K 0.63% 52
2015
Q2
$12M Sell
183,162
-711
-0.4% -$48.2K 0.6% 53
2015
Q1
$12.8M Sell
183,873
-794
-0.4% -$54.9K 0.64% 49
2014
Q4
$12.8M Sell
184,667
-1,029
-0.6% -$69.5K 0.63% 46
2014
Q3
$12.1M Sell
185,696
-1,270
-0.7% -$83.8K 0.62% 49
2014
Q2
$12.7M Sell
186,966
-1,335
-0.7% -$89.5K 0.65% 45
2014
Q1
$12.2M Sell
188,301
-2,373
-1% -$150K 0.65% 50
2013
Q4
$12.4M Sell
190,674
-3,153
-2% -$202K 0.67% 47
2013
Q3
$11.5M Sell
193,827
-9,283
-5% -$550K 0.67% 44
2013
Q2
$11.6M Buy
+203,110
New +$12.1M 0.7% 44

Other funds holding CL

HM Payson & Co's CL Position: Q2 2026 in Review

HM Payson & Co reduced its Colgate-Palmolive (CL) stake by 5.4% in Q2 2026, selling an estimated $296K and leaving 59,042 shares worth $5.41M. The position accounts for 0.07% of the portfolio, ranked #118.

HM Payson & Co first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.5M in Q2 2016. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • HM Payson & Co held 59,042 shares of Colgate-Palmolive worth $5.41M as of Q2 2026.
  • HM Payson & Co sold 3,388 Colgate-Palmolive shares in Q2 2026, an estimated $296K.
  • Colgate-Palmolive made up 0.07% of HM Payson & Co's portfolio in Q2 2026, its #118 holding.
  • HM Payson & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • HM Payson & Co's Colgate-Palmolive position peaked at $13.5M in Q2 2016.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.